Gerard M P, Hodgson D R, Lambeth R R, Ray S P, Rose R J
Faculty of Veterinary Science, University of Sydney, Camden, New South Wales, Australia.
Equine Vet J Suppl. 2002 Sep(34):496-501. doi: 10.1111/j.2042-3306.2002.tb05472.x.
The recent availability of recombinant equine somatotropin (eST) has led to concern about its use as an ergogenic aid in racehorses. This study was undertaken to investigate the changes in exercise capacity in maturing horses in a training programme, and to assess whether eST is an ergogenic aid to this group. We tested the hypothesis that the combination of training and eST, compared to training alone, would further improve exercise capacity in maturing Standardbreds, by virtue of ST's anabolic effects and potential to enhance cardiac function, circulating fluid volume and red cell mass. Twelve, untrained Standardbreds (mean +/- s.d. 20.7 +/- 1.1 months) were paired according to similar bodyweight and then assigned randomly to treatment or control group. The horses underwent a 12 week treadmill training programme. Methionyl eST (10 microg/kg for the first 7 days, then 20 microg/kg) was administered once daily, i.m., for 42 consecutive days (Weeks 4 to 9 inclusive) to 6 horses in the treatment group. All horses performed a standardised maximal exercise test to fatigue at Weeks 0, 3, 6, 9, and 12. During each exercise test VO2, VCO2, plasma lactate concentrations ([La]), heart rates, blood volume and total run time were measured. There was no significant effect of eST administration on VO2max, V200, V(LA4), LA9, red cell volume (RCV), plasma volume (PV), or run time to fatigue. Combining the data for all horses, training significantly altered the VO2max (mean +/- s.d. 98.2 +/- 11.1 ml/kg/min in Week 0 to 117.6 +/- 4.8 ml/kg/min in Week 12), V(LA4) (5.1 +/- 0.8 m/s to 7.4 +/- 1.0 m/s), LA9 (12.7 +/- 3.9 mmol/l to 7.1 +/- 1.9 mmol/l), RCV (46.3 +/- 4.7 ml/kg to 63.5 +/- 5.0 ml/kg), PV (46.0 +/- 4.8 ml/kg to 57.0 +/- 6.3 ml/kg), and run time to fatigue (431.8 +/- 30.9 to 490.2 +/- 30.5 s), but not V200 (5.0 +/- 0.5 m/s to 5.2 +/- 1.1 m/s). The administration of eST to young Standardbred horses in training did not significantly improve their exercise capacity or indices of fitness. However, these maturing horses demonstrated a rapid physiological response to training exercise. Further research is required to determine the relationship between exercise capacity and ST in the horse.
重组马生长激素(eST)的近期可得性引发了人们对其在赛马中用作提高运动成绩辅助剂的担忧。本研究旨在调查处于训练计划中的成长马匹运动能力的变化,并评估eST是否对该群体是一种提高运动成绩的辅助剂。我们检验了这样一个假设,即与单独训练相比,训练与eST的联合使用将凭借生长激素的合成代谢作用以及增强心脏功能、循环血容量和红细胞量的潜力,进一步提高成长中的标准赛马的运动能力。12匹未经训练的标准赛马(平均±标准差,20.7±1.1个月)根据相似体重配对,然后随机分配到治疗组或对照组。这些马接受了为期12周的跑步机训练计划。在治疗组的6匹马中,连续42天(第4周至第9周,包括第9周)每天一次肌肉注射蛋氨酰eST(前7天为10微克/千克,然后为20微克/千克)。所有马匹在第0、3、6、9和12周进行标准化的最大运动疲劳试验。在每次运动试验期间,测量耗氧量(VO2)、二氧化碳排出量(VCO2)、血浆乳酸浓度([La])、心率、血容量和总跑步时间。给予eST对最大耗氧量(VO2max)、V200、V(LA4)、LA9、红细胞量(RCV)、血浆量(PV)或疲劳跑步时间没有显著影响。综合所有马匹的数据,训练显著改变了最大耗氧量(平均±标准差,第0周时为98.2±11.1毫升/千克/分钟至第12周时为117.6±4.8毫升/千克/分钟)、V(LA4)(5.1±0.8米/秒至7.4±1.0米/秒)、LA9(12.7±3.9毫摩尔/升至7.1±1.9毫摩尔/升)、RCV(46.3±4.7毫升/千克至63.5±5.0毫升/千克)、PV(46.0±4.8毫升/千克至57.0±6.3毫升/千克)以及疲劳跑步时间(431.8±30.9秒至490.2±30.5秒),但未改变V200(5.0±0.5米/秒至5.2±1.1米/秒)。对处于训练中的年轻标准赛马给予eST并没有显著提高它们的运动能力或健康指标。然而,这些成长中的马匹对训练运动表现出快速的生理反应。需要进一步研究以确定马的运动能力与生长激素之间的关系。